The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study.
about
Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndromeA controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndromeAbdominal bloating: pathophysiology and treatmentMain ion channels and receptors associated with visceral hypersensitivity in irritable bowel syndromeReview article: the treatment of functional abdominal bloating and distension.Treatment of irritable bowel syndrome.Citalopram provides little or no benefit in nondepressed patients with irritable bowel syndrome.Fluoxetine in the treatment of irritable bowel syndrome.Irritable bowel syndrome: a review article.Effects on gastrointestinal functions and symptoms of serotonergic psychoactive agents used in functional gastrointestinal diseases.Bloating and functional gastro-intestinal disorders: where are we and where are we going?The treatment of irritable bowel syndromeEffect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis.Current and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents.Efficacy and Safety of Antidepressants for the Treatment of Irritable Bowel Syndrome: A Meta-Analysis.Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition.Potential Causes and Present Pharmacotherapy of Irritable Bowel Syndrome: An Overview.Review article: modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease.Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity.Serotonin receptor modulators in the treatment of irritable bowel syndrome.Mechanisms of serotonergic agents for treatment of gastrointestinal motility and functional bowel disorders.History of depressive and anxiety disorders and paroxetine response in patients with irritable bowel syndrome: post hoc analysis from a placebo-controlled study.New treatments for irritable bowel syndrome in womenChallenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles.Management Strategies for Abdominal Bloating and Distension.Current and novel therapeutic options for irritable bowel syndrome management.Asian consensus on irritable bowel syndrome.The use of psychotropic drugs in irritable bowel syndrome.Evaluating the functional net value of pharmacologic agents in treating irritable bowel syndrome.Selective serotonin reuptake inhibitors for the treatment of irritable bowel syndrome.Treatment of abdominal pain in irritable bowel syndrome.Metabolic kinetics of 5-hydroxytryptamine and the research targets of functional gastrointestinal disorders.American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation.Pain management in patients with inflammatory bowel disease: translational approaches from bench to bedside.Current and emerging pharmacotherapeutic options for irritable bowel syndrome.Centrally targeted pharmacotherapy for chronic abdominal pain.New Options in Constipation Management.Empirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD.Ion channels, ion channel receptors, and visceral hypersensitivity in irritable bowel syndrome.Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: A Review Article.
P2860
Q24234934-69926AB4-0563-4F9A-A062-3FCB5B75F4D3Q24680181-C29D8FAE-2F55-45FD-99A6-9088305C4A63Q26851622-7F81FE85-401E-4113-8B22-E4B976FCB649Q26862565-42463E95-0889-4ED5-A80B-3C1C314D023BQ33450132-3DF78798-E9C4-4E1C-A80E-D554A1D1C828Q33450370-4BDCCBDC-5EB7-47E6-9127-396BA88B7463Q33636450-E37B02E0-3608-4E8F-88BC-2ECCAA8500C3Q33828011-99191846-2125-431F-8412-84EBA88A3BB3Q34134491-11D6EFC5-B99D-40C9-9FC4-C2A5FE347098Q34318616-1C7838B0-BD4F-4ADE-ABD2-D8824994ABF1Q34366956-C5B83F52-6FDF-4D19-ADEA-43D4C52906F5Q34409009-A6B14265-3C91-4605-8AAA-4DA8336EE238Q34425086-2FB1C5B2-F78B-4371-A9C2-AB380A7F1354Q34478089-95067BDB-CA01-479E-8437-61569C59A83AQ34488657-DC1D11E5-E55F-45B7-88A4-40386FAA4F74Q35847101-01BB1139-3397-41B0-8FE7-9769E403D852Q35971357-137F2C3B-4EAE-4164-8691-89F28816A95BQ36583822-78F118FE-B016-4F0D-84C0-FD4EF4C0DDDEQ36728938-5A38F15D-E068-480C-A916-7C9BA6888EF5Q36822923-EB7181F4-A1AD-416A-8B2E-8D901A86EE30Q36874388-E9764D84-0CE2-4FA6-BB22-5A46758F5715Q37067979-2C4C6CDC-3D48-43AF-BC38-92813AA3BC34Q37120300-3DFF5074-E0A5-495A-9847-D61E2CBA6DBBQ37164063-E41DC3DF-352E-4100-8218-FC14D05FC6AEQ37190545-A7FB8DF5-851B-4677-966F-34D8A1C78080Q37438547-8F3B6B5C-D4C3-468C-9361-43B3BEA7BCC4Q37769278-39AF9171-5FE7-4134-8892-64CE3483FAC8Q38073816-24C3D593-8DE9-4E37-9F5A-6C074F1DD42DQ38194631-098C10FC-DCE8-4D5D-BA43-3CA4E1CE4C36Q38197845-184AD88F-8C12-44A8-9D16-C94B5753C2F7Q38213185-84EEA38C-A142-42BE-9F12-1FA6987198A1Q38219316-AAA22524-D598-432A-BDC0-FA9650300C30Q38236812-A45AF9AD-792C-4C0C-9F0F-9A7736F5662CQ38248113-68113E96-DC61-43F6-B504-DE794ECA5EAEQ38254747-1EE1A826-F224-4400-993F-E6DDAFAAC996Q38343940-29339DAD-3C89-4B01-933F-3CF0CB8F6C80Q38602701-E728B232-E1A8-4FCA-9211-D503BD25B979Q38831882-015F0BE3-AE4D-48E7-BEE6-A9C827725A85Q38990851-F5FF61B9-2E42-4010-ADC1-6E5E6D0B4E0DQ41392745-3AEE8BD2-C0C9-415C-9897-7DED5D268EFB
P2860
The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The effect of fluoxetine in pa ...... d randomized-controlled study.
@ast
The effect of fluoxetine in pa ...... d randomized-controlled study.
@en
The effect of fluoxetine in pa ...... d randomized-controlled study.
@nl
type
label
The effect of fluoxetine in pa ...... d randomized-controlled study.
@ast
The effect of fluoxetine in pa ...... d randomized-controlled study.
@en
The effect of fluoxetine in pa ...... d randomized-controlled study.
@nl
prefLabel
The effect of fluoxetine in pa ...... d randomized-controlled study.
@ast
The effect of fluoxetine in pa ...... d randomized-controlled study.
@en
The effect of fluoxetine in pa ...... d randomized-controlled study.
@nl
P2093
P2860
P1476
The effect of fluoxetine in pa ...... d randomized-controlled study.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2036.2005.02566.X
P407
P577
2005-09-01T00:00:00Z